Genetic and functional diversity of Pseudomonas aeruginosa lipopolysaccharide

Frontiers in Microbiology

Volumn 2, Issue JUNE, 2011, Pages

  Lam, Joseph S ^a   Taylor, Véronique L ^a   Islam, Salim T ^a   Hao, Youai ^a   Kocíncová, Dana ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Bacteriophage; Biosynthesis; Lipopolysaccharide; Motility; Nucleotide sugars; Seroconversion; Serotyping; Virulence

Indexed keywords

EID: 84865173458     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2011.00118     Document Type: Article

References (195)

1. Abeyrathne, P. D., Daniels, C., Poon, K. K., Matewish, M. J., and Lam, J. S. (2005). Functional characterization of WaaL, a ligase associated with linking O-antigen polysaccharide to the core of Pseudomonas aeruginosa lipopolysaccharide. J. Bacteriol. 187, 3002-3012.
2. Abeyrathne, P. D., and Lam, J. S. (2007). WaaL of Pseudomonas aeruginosa utilizes ATP in in vitro ligation of O antigen onto lipid A-core. Mol. Microbiol. 65, 1345-1359.
3. Anderson, P. (2010). Emerging therapies in cystic fibrosis. Ther. Adv. Respir. Dis. 4, 177-185.
4. Arsenault, T. L., Hughes, D. W., Maclean, D. B., Szarek, W. A., Kropinski, A. M. B., and Lam, J. S. (1991). Structural studies on the polysaccharide portion of 'A-band' lipopolysaccharide from a mutant (AK14O1) of Pseudomonas aeruginosa PAO1. Can. J. Chem. 69, 1273-1280.
5. Augustin, D. K., Song, Y., Baek, M. S., Sawa, Y., Singh, G., Taylor, B., Rubio-Mills, A., Flanagan, J. L., Wiener-Kronish, J. P., and Lynch, S. V. (2007). Presence or absence of lipopolysaccharide O antigens affects type III secretion by Pseudomonas aeruginosa. J. Bacteriol. 189, 2203-2209.
6. Backhed, F., Normark, S., Schweda, E. K., Oscarson, S., and Richter-Dahlfors, A. (2003). Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications. Microbes Infect. 5, 1057-1063.
7. Bagdian, G., Luderitz, O., and Staub, A. M. (1966). Immunochemical studies on Salmonella: XI chemical modification correlated with conversion of group B Salmonella by bacteriophage 27. Ann. N. Y. Acad. Sci. 133, 405-424.
8. Bajmoczi, M., Gadjeva, M., Alper, S. L., Pier, G. B., and Golan, D. E. (2009). Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa. Am. J. Physiol. Cell Physiol. 297, C263-C277.
9. Beckmann, F., Moll, H., Jager, K. E., and Zahringer, U. (1995). Preliminary communication 7-O-carbamoyl-lglycero-d-manno-heptose: a new core constituent in the lipopolysaccharide of Pseudomonas aeruginosa. Carbohydr. Res. 267, C3-C7.
10. Bedoux, G., Vallee-Rehel, K., Kooistra, O., Zahringer, U., and Haras, D. (2004). Lipid A components from Pseudomonas aeruginosa PAO1 (serotype O5) and mutant strains investigated by electrospray ionization ion-trap mass spectrometry. J. Mass. Spectrom. 39, 505-513.
11. Belanger, M., Burrows, L. L., and Lam, J. S. (1999). Functional analysis of genes responsible for the synthesis of the B-band O-antigen of Pseudomonas aeruginosa serotype O6 lipopolysaccharide. Microbiology 145, 3505-3521.
12. Bennett-Guerrero, E., Mcintosh, T. J., Barclay, G. R., Snyder, D. S., Gibbs, R. J., Mythen, M. G., and Poxton, I. R. (2000). Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharide vaccine. Infect. Immun. 68, 6202-6208.
13. Bhat, R., Marx, A., Galanos, C., and Conrad, R. S. (1990). Structural studies of lipid A from Pseudomonas aeruginosa PAO1: occurrence of 4-amino-4-deoxyarabinose. J. Bacteriol. 172, 6631-6636.
14. Bishop, R. E. (2005). Fundamentals of endotoxin structure and function. Contrib. Microbiol. 12, 1-27.
15. Bufler, P., Schmidt, B., Schikor, D., Bauernfeind, A., Crouch, E. C., and Griese, M. (2003). Surfactant protein A and D differently regulate the immune response to nonmucoid Pseudomonas aeruginosa and its lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 28, 249-256.
16. Burrows, L. L., Charter, D. F., and Lam, J. S. (1996). Molecular characterization of the Pseudomonas aeruginosa serotype O5 (PAO1) B-band lipopolysaccharide gene cluster. Mol. Microbiol. 22, 481-495.
17. Burrows, L. L., Chow, D., and Lam, J. S. (1997). Pseudomonas aeruginosa B-band O-antigen chain length is modulated by Wzz (Ro1). J. Bacteriol. 179, 1482-1489.
18. Burrows, L. L., and Lam, J. S. (1999). Effect of wzx (rfbX) mutations on A-band and B-band lipopolysaccharide biosynthesis in Pseudomonas aeruginosa O5. J. Bacteriol. 181, 973-980.
19. Bystrova, O. V., Knirel, Y. A., Lindner, B., Kocharova, N. A., Kondakova, A. N., Zahringer, U., and Pier, G. B. (2006). Structures of the core oligosaccharide and O-units in the R-and SR-type lipopolysaccharides of reference strains of Pseudomonas aeruginosa O-serogroups. FEMS Immunol. Med. Microbiol. 46, 85-99.
20. Cavenagh, M. M., and Miller, R. V. (1986). Specialized transduction of Pseudomonas aeruginosa PAO by bacteriophage D3. J. Bacteriol. 165, 448-452.
21. Cerantola, S., and Montrozier, H. (1997). Structural elucidation of two polysaccharides present in the lipopolysaccharide of a clinical isolate of Burkholderia cepacia. Eur. J. Biochem. 246, 360-366.
22. Ceyssens, P.-J., and Lavigne, R. (2010). Bacteriophages of Pseudomonas. Future Microbiol. 5, 1041-1055.
23. Choudhury, B., Carlson, R. W., and Goldberg, J. B. (2005). The structure of the lipopolysaccharide from a galU mutant of Pseudomonas aeruginosa serogroup-O11. Carbohydr. Res. 340, 2761-2772.
24. Choudhury, B., Carlson, R. W., and Goldberg, J. B. (2008). Characterization of the lipopolysaccharide from a wbjE mutant of the serogroup O11 Pseudomonas aeruginosa strain, PA103. Carbohydr. Res. 343, 238-248.
25. Creuzenet, C., and Lam, J. S. (2001). Topological and functional characterization of WbpM, an inner membrane UDP-GlcNAc C6 dehydratase essential for lipopolysaccharide biosynthesis in Pseudomonas aeruginosa. Mol. Microbiol. 41, 1295-1310.
26. Cryz, S. J., Jr., Pitt, T. L., Furer, E., and Germanier, R. (1984). Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect. Immun. 44, 508-513.
27. Currie, H. L., Lightfoot, J., and Lam, J. S. (1995). Prevalence of gca, a gene involved in synthesis of A-band common antigen polysaccharide in Pseudomonas aeruginosa. Clin. Diagn. Lab. Immunol. 2, 554-562.
28. Da Silva Correia, J., Soldau, K., Christen, U., Tobias, P. S., and Ulevitch, R. J. (2001). Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276, 21129-21135.
29. Daniels, C., Griffiths, C., Cowles, B., and Lam, J. S. (2002). Pseudomonas aeruginosa O-antigen chain length is determined before ligation to lipid A core. Environ. Microbiol. 4, 883-897.
30. Dasgupta, T., De Kievit, T. R., Masoud, H., Altman, E., Richards, J. C., Sadovskaya, I., Speert, D. P., and Lam, J. S. (1994). Characterization of lipopolysaccharide-deficient mutants of Pseudomonas aeruginosa derived from serotypes O3, O5, and O6. Infect. Immun. 62, 809-817.
31. De Kievit, T. R., Dasgupta, T., Schweizer, H., and Lam, J. S. (1995). Molecular cloning and characterization of the rfc gene of Pseudomonas aeruginosa (serotype O5). Mol. Microbiol. 16, 565-574.
32. De Kievit, T. R., and Lam, J. S. (1994). Monoclonal antibodies that distinguish inner core, outer core, and lipid A regions of Pseudomonas aeruginosa lipopolysaccharide. J. Bacteriol. 176, 7129-7139.
33. De Kievit, T. R., and Lam, J. S. (1997). Isolation and characterization of two genes, waaC (rfaC) and waaF (rfaF), involved in Pseudomonas aeruginosa serotype O5 inner-core biosynthesis. J. Bacteriol. 179, 3451-3457.
34. Dean, C. R., Franklund, C. V., Retief, J. D., Coyne, M. J. Jr., Hatano, K., Evans, D. J., Pier, G. B., and Goldberg, J. B. (1999). Characterization of the serogroup O11 O-antigen locus of Pseudomonas aeruginosa PA103. J. Bacteriol. 181, 4275-4284.
35. Dean, C. R., and Goldberg, J. B. (2000). The wbpM gene in Pseudomonas aeruginosa serogroup O17 resides on a cryptic copy of the serogroup O11 O antigen gene locus. FEMS Microbiol. Lett. 187, 59-63.
36. Digiandomenico, A., Rao, J., Harcher, K., Zaidi, T. S., Gardner, J., Neely, A. N., Pier, G. B., and Goldberg, J. B. (2007). Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections. Proc. Natl. Acad. Sci. U.S.A. 104, 4624-4629.
37. Dotson, G. D., Kaltashov, I. A., Cotter, R. J., and Raetz, C. R. (1998). Expression cloning of a Pseudomonas gene encoding a hydroxydecanoyl-acyl carrier protein-dependent UDP-GlcNAc acyltransferase. J. Bacteriol. 180, 330-337.
38. Dunkelberger, J. R., and Song, W. C. (2010). Complement and its role in innate and adaptive immune responses. Cell Res. 20, 34-50.
39. Edson, R. S., and Terrell, C. L. (1999). The aminoglycosides. Mayo Clin. Proc. 74, 519-528.
40. Ernst, R. K., Adams, K. N., Moskowitz, S. M., Kraig, G. M., Kawasaki, K., Stead, C. M., Trent, M. S., and Miller, S. I. (2006). The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway. J. Bacteriol. 188, 191-201.
41. Ernst, R. K., Hajjar, A. M., Tsai, J. H., Moskowitz, S. M., Wilson, C. B., and Miller, S. I. (2003). Pseudomonas aeruginosa lipid A diversity and its recognition by Toll-like receptor 4. J. Endotoxin. Res. 9, 395-400.
42. Ernst, R. K., Moskowitz, S. M., Emerson, J. C., Kraig, G. M., Adams, K. N., Harvey, M. D., Ramsey, B., Speert, D. P., Burns, J. L., and Miller, S. I. (2007). Unique lipid A modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis. J. Infect. Dis. 196, 1088-1092.
43. Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M., and Miller, S. I. (1999). Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286, 1561-1565.
44. Erridge, C., Stewart, J., Bennett-Guerrero, E., Mcintosh, T. J., and Poxton, I. R. (2002). The biological activity of a liposomal complete core lipopolysaccharide vaccine. J. Endotoxin. Res. 8, 39-46.
45. Feldman, M., Bryan, R., Rajan, S., Scheffler, L., Brunnert, S., Tang, H., and Prince, A. (1998). Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect. Immun. 66, 43-51.
46. Fuqua, W. C., Winans, S. C., and Greenberg, E. P. (1994). Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. J. Bacteriol. 176, 269-275.
47. Garbe, J., Wesche, A., Bunk, B., Kazmierczak, M., Selezska, K., Rohde, C., Sikorski, J., Rohde, M., Jahn, D., and Schobert, M. (2010). Characterization of JG024, a Pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions. BMC Microbiol. 10, 301. doi: 10.1186/1471-2180-10-301
48. Ghanei, H., Abeyrathne, P. D., and Lam, J. S. (2007). Biochemical characterization of MsbA from Pseudomonas aeruginosa. J. Biol. Chem. 282, 26939-26947.
49. Gibbons, H. S., Lin, S., Cotter, R. J., and Raetz, C. R. (2000). Oxygen requirement for the biosynthesis of the S-2-hydroxymyristate moiety in Salmonella typhimurium lipid A. Function of LpxO, A new Fe2+/ alpha-ketoglutarate-dependent dioxygenase homologue. J. Biol. Chem. 275, 32940-32949.
50. Gibbons, H. S., Reynolds, C. M., Guan, Z., and Raetz, C. R. (2008). An inner membrane dioxygenase that generates the 2-hydroxymyristate moiety of Salmonella lipid A. Biochemistry 47, 2814-2825.
51. Gibson, R. L., Burns, J. L., and Ramsey, B. W. (2003). Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168, 918-951.
52. Goldman, R. C., Doran, C. C., Kadam, S. K., and Capobianco, J. O. (1988). Lipid A precursor from Pseudomonas aeruginosa is completely acylated prior to addition of 3-deoxy-d-manno-octulosonate. J. Biol. Chem. 263, 5217-5223.
53. Guo, L., Lim, K. B., Gunn, J. S., Bainbridge, B., Darveau, R. P., Hackett, M., and Miller, S. I. (1997). Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276, 250-253.
54. Guo, L., Lim, K. B., Poduje, C. M., Daniel, M., Gunn, J. S., Hackett, M., and Miller, S. I. (1998). Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95, 189-198.
55. Gupta, S. K., Masinick, S., Garrett, M., and Hazlett, L. D. (1997). Pseudomonas aeruginosa lipopolysaccharide binds galectin-3 and other human corneal epithelial proteins. Infect. Immun. 65, 2747-2753.
56. Hajjar, A. M., Ernst, R. K., Tsai, J. H., Wilson, C. B., and Miller, S. I. (2002). Human toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3, 354-359.
57. Hall-Stoodley, L., Costerton, J. W., and Stoodley, P. (2004). Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2, 95-108.
58. Hancock, R. E., and Diamond, G. (2000). The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8, 402-410.
59. Hancock, R. E., Mutharia, L. M., Chan, L., Darveau, R. P., Speert, D. P., and Pier, G. B. (1983). Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect. Immun. 42, 170-177.
60. Hanlon, G. W. (2007). Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int. J. Antimicrob. Agents 30, 118-128.
61. Hauser, A. R. (2009). The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat. Rev. Microbiol. 7, 654-665.
62. Hayashi, T., Matsumoto, H., Ohnishi, M., Yokota, S., Shinomiya, T., Kageyama, M., and Terawaki, Y. (1994). Cytotoxin-converting phages, phi CTX and PS21, are R pyocin-related phages. FEMS Microbiol. Lett. 122, 239-244.
63. Hoiby, N., Ciofu, O., and Bjarnsholt, T. (2010). Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol. 5, 1663-1674.
64. Holloway, B. W., and Cooper, G. N. (1962). Lysogenic conversion in Pseudomonas aeruginosa. J. Bacteriol. 84, 1321-1324.
65. Holmskov, U., Thiel, S., and Jensenius, J. C. (2003). Collectins and ficolins: humoral lectins of the innate immune defense. Annu. Rev. Immunol. 21, 547-578.
66. Islam, S. T., Gold, A. C., Taylor, V. L., Anderson, E. M., Ford, R. C., and Lam, J. S. (2011). Dual conserved periplasmic loops possess essential charge characteristics that support a catch-and-release mechanism of O-antigen polymerization by Wzy in Pseudomonas aeruginosa PAO1. J. Biol. Chem. 286, 20600-20605.
67. Islam, S. T., Taylor, V. L., Qi, M., and Lam, J. S. (2010). Membrane topology mapping of the O-antigen flippase (Wzx), polymerase (Wzy), and ligase (WaaL) from Pseudomonas aeruginosa PAO1 reveals novel domain architectures. mBio 1, e00189-10.
68. Ivanov, I. E., Kintz, E. N., Porter, L. A., Goldberg, J. B., Burnham, N. A., and Camesano, T. A. (2011). Relating the physical properties of Pseudomonas aeruginosa lipopolysaccharides to virulence by atomic force microscopy. J. Bacteriol. 193, 1259-1266.
69. Janeway, C. A. Jr., and Medzhitov, R. (2002). Innate immune recognition. Annu. Rev. Immunol. 20, 197-216.
70. Jarrell, K. F., and Kropinski, A. M. (1981a). Isolation and characterization of a bacteriophage specific for the lipopolysaccharide of rough derivatives of Pseudomonas aeruginosa strain PAO. J. Virol. 38, 529-538.
71. Jarrell, K. F., and Kropinski, A. M. (1981b). Pseudomonas aeruginosa bacteriophage phi PLS27-lipopolysaccharide interactions. J. Virol. 40, 411-420.
72. Jones, R. J., Roe, E. A., and Gupta, J. L. (1979). Controlled trials of a polyvalent Pseudomonas vaccine in burns. Lancet 314, 977-983.
73. Kadurugamuwa, J. L., Clarke, A. J., and Beveridge, T. J. (1993a). Surface action of gentamicin on Pseudomonas aeruginosa. J. Bacteriol. 175, 5798-5805.
74. Kadurugamuwa, J. L., Lam, J. S., and Beveridge, T. J. (1993b). Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect. Antimicrob. Agents Chemother. 37, 715-721.
75. Kaluzny, K., Abeyrathne, P. D., and Lam, J. S. (2007). Coexistence of two distinct versions of O-antigen polymerase, Wzy-alpha and Wzy-beta, in Pseudomonas aeruginosa serogroup O2 and their contributions to cell surface diversity. J. Bacteriol. 189, 4141-4152.
76. Kidd, T. J., Grimwood, K., Ramsay, K. A., Rainey, P. B., and Bell, S. C. (2011). Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosis. J. Clin. Microbiol. 49, 263-268.
77. King, J. D., Kocincova, D., Westman, E. L., and Lam, J. S. (2009). Review: lipopolysaccharide biosynthesis in Pseudomonas aeruginosa. Innate Immun. 15, 261-312.
78. King, J. D., Vinogradov, E., Tran, V., and Lam, J. S. (2010). Biosynthesis of uronamide sugars in Pseudomonas aeruginosa O6 and Escherichia coli O121 O-Antigens. Environ. Microbiol. 12, 1531-1544.
79. Kintz, E., Scarff, J. M., Digiandomenico, A., and Goldberg, J. B. (2008). Lipopolysaccharide O-antigen chain length regulation in Pseudomonas aeruginosa serogroup O11 strain PA103. J. Bacteriol. 190, 2709-2716.
80. Kishore, U., Wang, J.-Y., Hoppe, H.-J., and Reid, K. B. M. (1996). The (-helical neck region of human lung surfactant protein D is essential for the binding of the carbohydrate recognition domains to lipopolysaccharides and phospholipids. Biophys. J. 318, 505-511.
81. Klausen, M., Heydorn, A., Ragas, P., Lambertsen, L., Aaes-Jørgensen, A., Molin, S., and Tolker-Nielsen, T. (2003). Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol. Microbiol. 48, 1511-1524.
82. Kneidinger, B., O'riordan, K., Li, J., Brisson, J. -R., Lee, J. C., and Lam, J. S. (2003). Three highly conserved proteins catalyze the conversion of UDP-N-acetyl-d-glucosamine to precursors for the biosynthesis of O-Antigen in Pseudomonas aeruginosa O11 and capsule in Staphylococcus aureus Type 5. J. Biol. Chem. 278, 3615-3627.
83. Knirel, Y. A., Bystrova, O. V., Kocharova, N. A., Zahringer, U., and Pier, G. B. (2006). Conserved and variable structural features in the lipopolysaccharide of Pseudomonas aeruginosa. J. Endotoxin. Res. 12, 324-336.
84. Kocharova, N. A., Knirel' Iu, A., Kochetkov, N. K., and Stanislavskii, E. S. (1988). Characteristics of rhamnan isolated from preparations of Pseudomonas aeruginosa lipopolysaccharides. Bioorg. Khim. 14, 701-703.
85. Kocíncová, D., Hao, Y., Vinogradov, E., and Lam, J. S. (2011). Evidence that WapB is an 1,2 glucosyltransferase of Pseudomonas aeruginosa involved in LPS outer core biosynthesis. J. Bacteriol. 193, 2708-2716.
86. Kocíncová, D., and Lam, J. S. (2011). Structural diversity of core oligosaccharide domain of P. aeruginosa lipopolysaccharide. Biochemistry (Mosc.) (accepted).
87. Köhler, T., Curty, L. K., Barja, F., Van Delden, C., and Pechère, J. -C. (2000). Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J. Bacteriol. 182, 5990-5996.
88. Köhler, T., Donner, V., and Van Delden, C. (2010). Lipopolysaccharide as shield and receptor for R-pyocin-mediated killing in Pseudomonas aeruginosa. J. Bacteriol. 192, 1921-1928.
89. Kooistra, O., Bedoux, G., Brecker, L., Lindner, B., Sanchez Carballo, P., Haras, D., and Zahringer, U. (2003). Structure of a highly phosphorylated lipopolysaccharide core in the Delta algC mutants derived from Pseudomonas aeruginosa wild-type strains PAO1 (serogroup O5) and PAC1R (serogroup O3). Carbohydr. Res. 338, 2667-2677.
90. Koval, S. F., and Meadow, P. M. (1977). The isolation and characterization of lipopolysaccharide-defective mutants of Pseudomonas aeruginosa PAC1. J. Gen. Microbiol. 98, 387-398.
91. Kresse, A. U., Dinesh, S. D., Larbig, K., and Römling, U. (2003). Impact of large chromosomal inversions on the adaptation and evolution of Pseudomonas aeruginosa chronically colonizing cystic fibrosis lungs. Mol. Microbiol. 47, 145-158.
92. Kropinski, A. M., Farinha, M. A., and Jansons, I. (1994). Nucleotide sequence of the Pseudomonas aeruginosa insertion sequence IS222: another member of the IS3 family. Plasmid 31, 222-228.
93. Kulshin, V. A., Zahringer, U., Lindner, B., Jager, K. E., Dmitriev, B. A., and Rietschel, E. T. (1991). Structural characterization of the lipid A component of Pseudomonas aeruginosa wild-type and rough mutant lipopolysaccharides. Eur. J. Biochem. 198, 697-704.
94. Kunkel, T. A., and Erie, D. A. (2005). DNA mismatch repair. Annu. Rev. Biochem. 74, 681-710.
95. Kuzio, J., and Kropinski, A. M. (1983). O-antigen conversion in Pseudomonas aeruginosa PAO1 by bacteriophage D3. J. Bacteriol. 155, 203-212.
96. Lam, J. S., Macdonald, L. A., and Lam, M. Y. (1987a). Production of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa. Infect. Immun. 55, 2854-2856.
97. Lam, J. S., Macdonald, L. A., Lam, M. Y., Duchesne, L. G., and Southam, G. G. (1987b). Production and characterization of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa. Infect. Immun. 55, 1051-1057.
98. Lam, M. Y., Mcgroarty, E. J., Kropinski, A. M., Macdonald, L. A., Pedersen, S. S., Hoiby, N., and Lam, J. S. (1989). Occurrence of a common lipopolysaccharide antigen in standard and clinical strains of Pseudomonas aeruginosa. J. Clin. Microbiol. 27, 962-967.
99. Lang, A. B., Rüdeberg, A., Schöni, M. H., Que, J. U., Fürer, E., and Schaad, U. B. (2004). Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection. Pediatr. Infect. Dis. J. 23, 504-510.
100. Lang, A. B., Schaad, U. B., Rüdeberg, A., Wedgwood, J., Que, J. U., Fürer, E., and Cryz, J. S. J. (1995). Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis. J. Pediatr. 127, 711-717.
101. Lau, P. C. Y., Dutcher, J. R., Beveridge, T. J., and Lam, J. S. (2009a). Absolute quantitation of bacterial biofilm adhesion and viscoelasticity by microbead force spectroscopy. Biophys. J. 96, 2935-2948.
102. Lau, P. C. Y., Lindhout, T., Beveridge, T. J., Dutcher, J. R., and Lam, J. S. (2009b). Differential lipopolysaccharide core capping leads to quantitative and correlated modifications of mechanical and structural properties in Pseudomonas aeruginosa biofilms. J. Bacteriol. 191, 6618-6631.
103. Leclerc, J. E., Li, B., Payne, W. L., and Cebula, T. A. (1996). High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274, 1208-1211.
104. Lee, D. G., Urbach, J. M., Wu, G., Liberati, N. T., Feinbaum, R. L., Miyata, S., Diggins, L. T., He, J., Saucier, M., Deziel, E., Friedman, L., Li, L., Grills, G., Montgomery, K., Kucherlapati, R., Rahme, L. G., and Ausubel, F. M. (2006). Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol. 7, R90.
105. Levine, A. M., Kurak, K. E., Bruno, M. D., Stark, J. M., Whitsett, J. A., and Korfhagen, T. R. (1998). Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am. J. Respir. Cell Mol. Biol. 19, 700-708.
106. Lightfoot, J., and Lam, J. S. (1991). Molecular cloning of genes involved with expression of A-band lipopolysaccharide, an antigenically conserved form, in Pseudomonas aeruginosa. J. Bacteriol. 173, 5624-5630.
107. Lightfoot, J., and Lam, J. S. (1993). Chromosomal mapping, expression and synthesis of lipopolysaccharide in Pseudomonas aeruginosa: a role for guanosine diphospho (GDP)-dmannose. Mol. Microbiol. 8, 771-782.
108. Lindhout, T., Lau, P. C. Y., Brewer, D., and Lam, J. S. (2009). Truncation in the core oligosaccharide of lipopolysaccharide affects flagella-mediated motility in Pseudomonas aeruginosa PAO1 via modulation of cell surface attachment. Microbiology 155, 3449-3460.
109. Liu, P. V., Matsumoto, H., Kusama, H., and Bergan, T. O. M. (1983). Survey of heat-stable, major somatic antigens of Pseudomonas aeruginosa. Int. J. Syst. Bacteriol. 33, 256-264.
110. Liu, P. V., and Wang, S. (1990). Three new major somatic antigens of Pseudomonas aeruginosa. J. Clin. Microbiol. 28, 922-925.
111. Lyczak, J. B., Cannon, C. L., and Pier, G. B. (2000). Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2, 1051-1060.
112. Ma, S., Selvaraj, U., Ohman, D. E., Quarless, R., Hassett, D. J., and Wozniak, D. J. (1998). Phosphorylation-independent activity of the response regulators AlgB and AlgR in promoting alginate biosynthesis in mucoid Pseudomonas aeruginosa. J. Bacteriol. 180, 956-968.
113. Macfarlane, E. L., Kwasnicka, A., and Hancock, R. E. (2000). Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Microbiology 146(Pt 10), 2543-2554.
114. Macintyre, S., Lucken, R., and Owen, P. (1986). Smooth lipopolysaccharide is the major protective antigen for mice in the surface extract from IATS serotype 6 contributing to the polyvalent Pseudomonas aeruginosa vaccine PEV. Infect. Immun. 52, 76-84.
115. Mariencheck, W. I., Savov, J., Dong, Q., Tino, M. J., and Wright, J. R. (1999). Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of P. aeruginosa. Am. J. Physiol. 277, L777-L786.
116. Martin, N. L., and Beveridge, T. J. (1986). Gentamicin interaction with Pseudomonas aeruginosa cell envelope. Antimicrob. Agents Chemother. 29, 1079-1087.
117. Masoud, H., Altman, E., Richards, J. C., and Lam, J. S. (1994). General strategy for structural analysis of the oligosaccharide region of lipooligosaccharides. Structure of the oligosaccharide component of Pseudomonas aeruginosa IATS serotype 06 mutant R5 rough-type lipopolysaccharide. Biochemistry 33, 10568-10578.
118. Matewish, M. (2004). The Functional Role of Lipopolysaccharide in the Cell Envelope and Surface Proteins of Pseudomonas aeruginosa. Ph.D. thesis, University of Guelph, Guelph, ON, Canada.
119. Mcphee, J. B., Bains, M., Winsor, G., Lewenza, S., Kwasnicka, A., Brazas, M. D., Brinkman, F. S., and Hancock, R. E. (2006). Contribution of the PhoP-PhoQ and PmrA-PmrB two-component regulatory systems to Mg2+-induced gene regulation in Pseudomonas aeruginosa. J. Bacteriol. 188, 3995-4006.
120. Mcphee, J. B., Lewenza, S., and Hancock, R. E. (2003). Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 50, 205-217.
121. Meadow, P. M., and Wells, P. L. (1978). Receptor sites for R-type pyocins and bacteriophage E79 in the Core Part of the lipopolysaccharide of Pseudomonas aeruginosa PAC1. J. Gen. Microbiol. 108, 339-343.
122. Mena, A., Smith, E. E., Burns, J. L., Speert, D. P., Moskowitz, S. M., Perez, J. L., and Oliver, A. (2008). Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J. Bacteriol. 190, 7910-7917.
123. Michel-Briand, Y., and Baysse, C. (2002). The pyocins of Pseudomonas aeruginosa. Biochimie 84, 499-510.
124. Miller, R. V., Pemberton, J. M., and Richards, K. E. (1974). F116, D3 and G101: temperate bacteriophages of Pseudomonas aeruginosa. Virology 59, 566-569.
125. Miller, S. I., Ernst, R. K., and Bader, M. W. (2005). LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 3, 36-46.
126. Miller, W. L., Wenzel, C. Q., Daniels, C., Larocque, S., Brisson, J. R., and Lam, J. S. (2004). Biochemical characterization of WbpA, a UDP-N-acetyl-d-glucosamine 6-dehydrogenase involved in O-antigen biosynthesis in Pseudomonas aeruginosa PAO1. J. Biol. Chem. 279, 37551-37558.
127. Mohan, S., Kelly, T. M., Eveland, S. S., Raetz, C. R., and Anderson, M. S. (1994). An Escherichia coli gene (fabZ) encoding (3R)-hydroxymyristoyl acyl carrier protein dehydrase. Relation to fabA and suppression of mutations in lipid A biosynthesis. J. Biol. Chem. 269, 32896-32903.
128. Moskowitz, S. M., and Ernst, R. K. (2010). The role of Pseudomonas lipopolysaccharide in cystic fibrosis airway infection. Subcell. Biochem. 53, 241-253.
129. Moskowitz, S. M., Ernst, R. K., and Miller, S. I. (2004). PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J. Bacteriol. 186, 575-579.
130. Mueller-Ortiz, S. L., Drouin, S. M., and Wetsel, R. A. (2004). The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia. Infect. Immun. 72, 2899-2906.
131. Mutharia, L. M., and Lam, J. S. (2007). "Antigen-antibody reactions," in Methods for General and Molecular Microbiology, 3rd Edn, eds C. A. Reddy, T. J. Beveridge, J. A. Breznak, G. A. Marzluf, T. M. Schmidt, and L. R. Snyder (Washington, DC: ASM Press), 138-167.
132. Newton, G. J., Daniels, C., Burrows, L. L., Kropinski, A. M., Clarke, A. J., and Lam, J. S. (2001). Three-component-mediated serotype conversion in Pseudomonas aeruginosa by bacteriophage D3. Mol. Microbiol. 39, 1237-1247.
133. Ni, M., Evans, D. J., Hawgood, S., Anders, E. M., Sack, R. A., and Fleiszig, S. M. J. (2005). Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa. Infect. Immun. 73, 2147-2156.
134. O'toole, G. A., and Kolter, R. (1998). Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30, 295-304.
135. Oberhardt, M. A., Goldberg, J. B., Hogardt, M., and Papin, J. A. (2010). Metabolic network analysis of Pseudomonas aeruginosa during chronic cystic fibrosis lung infection. J. Bacteriol. 192, 5534-5548.
136. Ojeniyi, B., Lam, J. S., Hoiby, N., and Rosdahl, V. T. (1989). A comparison of the efficiency in serotyping of Pseudomonas aeruginosa from cystic fibrosis patients using monoclonal and polyclonal antibodies. APMIS 97, 631-636.
137. Ojeniyi, B., Wolz, C., Doring, G., Lam, J. S., Rosdahl, V. T., and Hoiby, N. (1990). Typing of polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients. APMIS 98, 423-431.
138. Oliver, A., Baquero, F., and Blázquez, J. (2002). The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol. Microbiol. 43, 1641-1650.
139. Oliver, A., Cantón, R., Campo, P., Baquero, F., and Blázquez, J. (2000). High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251-1253.
140. Ovod, V., Rudolph, K., Knirel, Y., and Krohn, K. (1996). Immunochemical characterization of O polysaccharides composing the alpha-d-rhamnose backbone of lipopolysaccharide of Pseudomonas syringae and classification of bacteria into serogroups O1 and O2 with monoclonal antibodies. J. Bacteriol. 178, 6459-6465.
141. Palsson-Mcdermott, E. M., and O'neill, L. A. (2004). Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113, 153-162.
142. Pennington, J. E., Reynolds, H. Y., Wood, R. E., Robinson, R. A., and Levine, A. S. (1975). Use of a Pseudomonas aeruginosa vaccine in patients with acute leukemia and cystic fibrosis. Am. J. Med. 58, 629-636.
143. Pier, G. B., Grout, M., and Zaidi, T. S. (1997). Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc. Natl. Acad. Sci. U.S.A. 94, 12088-12093.
144. Pier, G. B., Grout, M., Zaidi, T. S., Olsen, J. C., Johnson, L. G., Yankaskas, J. R., and Goldberg, J. B. (1996). Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271, 64-67.
145. Poon, K. K., Westman, E. L., Vinogradov, E., Jin, S., and Lam, J. S. (2008). Functional characterization of MigA and WapR: putative rhamnosyltransferases involved in outer core oligosaccharide biosynthesis of Pseudomonas aeruginosa. J. Bacteriol. 190, 1857-1865.
146. Postle, A. D., Mander, A., Reid, K. B. M., Wang, J. -Y., Wright, S. M., Moustaki, M., and Warner, J. O. (1999). Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 20, 90-98.
147. Raetz, C. R., and Whitfield, C. (2002). Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71, 635-700.
148. Raymond, C. K., Sims, E. H., Kas, A., Spencer, D. H., Kutyavin, T. V., Ivey, R. G., Zhou, Y., Kaul, R., Clendenning, J. B., and Olson, M. V. (2002). Genetic variation at the O-antigen biosynthetic locus in Pseudomonas aeruginosa. J. Bacteriol. 184, 3614-3622.
149. Restrepo, C. I., Dong, Q., Savov, J., Mariencheck, W. I., and Wright, J. R. (1999). Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 21, 576-585.
150. Rivera, M., Bryan, L. E., Hancock, R. E., and Mcgroarty, E. J. (1988). Heterogeneity of lipopolysaccharides from Pseudomonas aeruginosa: analysis of lipopolysaccharide chain length. J. Bacteriol. 170, 512-521.
151. Rivera, M., Chivers, T. R., Lam, J. S., and Mcgroarty, E. J. (1992). Common antigen lipopolysaccharide from Pseudomonas aeruginosa AK1401 as a receptor for bacteriophage A7. J. Bacteriol. 174, 2407-2411.
152. Robbins, P. W., Keller, J. M., Wright, A., and Bernstein, R. L. (1965). Enzymatic and kinetic studies on the mechanism of O-Antigen conversion by bacteriophage epsilon-15. J. Biol. Chem. 240, 384-390.
153. Robertson, D. M., Petroll, W. M., Jester, J. V., and Cavanagh, H. D. (2007). Current concepts: contact lens related Pseudomonas keratitis. Cont. Lens Anterior Eye 30, 94-107.
154. Rocchetta, H. L., Burrows, L. L., Pacan, J. C., and Lam, J. S. (1998a). Three rhamnosyltransferases responsible for assembly of the A-band d-rhamnan polysaccharide in Pseudomonas aeruginosa: a fourth transferase, WbpL, is required for the initiation of both A-band and B-band lipopolysaccharide synthesis. Mol. Microbiol. 28, 1103-1119.
155. Rocchetta, H. L., and Lam, J. S. (1997). Identification and functional characterization of an ABC transport system involved in polysaccharide export of A-band lipopolysaccharide in Pseudomonas aeruginosa. J. Bacteriol. 179, 4713-4724.
156. Rocchetta, H. L., Pacan, J. C., and Lam, J. S. (1998b). Synthesis of the A-band polysaccharide sugar d-rhamnose requires Rmd and WbpW: identification of multiple AlgA homologues, WbpW and ORF488, in Pseudomonas aeruginosa. Mol. Microbiol. 29, 1419-1434.
157. Roy, P. H., Tetu, S. G., Larouche, A., Elbourne, L., Tremblay, S., Ren, Q., Dodson, R., Harkins, D., Shay, R., Watkins, K., Mahamoud, Y., and Paulsen, I. T. (2010). Complete genome sequence of the multiresistant taxonomic outlier Pseudomonas aeruginosa PA7. PLoS ONE 5, e8842. doi: 10.1371/journal.pone.0008842
158. Sadovskaya, I., Brisson, J. R., Lam, J. S., Richards, J. C., and Altman, E. (1998). Structural elucidation of the lipopolysaccharide core regions of the wild-type strain PAO1 and O-chain-deficient mutant strains AK1401 and AK1012 from Pseudomonas aeruginosa serotype O5. Eur. J. Biochem. 255, 673-684.
159. Sanchez Carballo, P. M., Rietschel, E. T., Kosma, P., and Zahringer, U. (1999). Elucidation of the structure of an alanine-lacking core tetrasaccharide trisphosphate from the lipopolysaccharide of Pseudomonas aeruginosa mutant H4. Eur. J. Biochem. 261, 500-508.
160. Sawada, S., Kawamura, T., Masuho, Y., and Tomibe, K. (1985). A new common polysaccharide antigen of strains of Pseudomonas aeruginosa detected with a monoclonal antibody. J. Infect. Dis. 152, 1290-1299.
161. Schiller, N., Hackley, D., and Morrison, A. (1984). Isolation and characterization of serum-resistant strains of Pseudomonas aeruginosa derived from serum-sensitive parental strains. Curr. Microbiol. 10, 185-189.
162. Schiller, N. L., Hatch, R. A., and Joiner, K. A. (1989). Complement activation and C3 binding by serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa. Infect. Immun. 57, 1707-1713.
163. Schmidt, K. D., Tümmler, B., and Römling, U. (1996). Comparative genome mapping of Pseudomonas aeruginosa PAO with P. aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats. J. Bacteriol. 178, 85-93.
164. Sedlak-Weinstein, E., Cripps, A. W., Kyd, J. M., and Foxwell, A. R. (2005). Pseudomonas aeruginosa: the potential to immunise against infection. Expert Opin. Biol. Ther. 5, 967-982.
165. Senchenkova, S. N., Huang, X., Laux, P., Knirel, Y. A., Shashkov, A. S., and Rudolph, K. (2002). Structures of the O-polysaccharide chains of the lipopolysaccharides of Xanthomonas campestris pv phaseoli var fuscans GSPB 271 and X. campestris pv malvacearum GSPB 1386 and GSPB 2388. Carbohydr. Res. 337, 1723-1728.
166. Silby, M. W., Cerdeno-Tarraga, A. M., Vernikos, G. S., Giddens, S. R., Jackson, R. W., Preston, G. M., Zhang, X. X., Moon, C. D., Gehrig, S. M., Godfrey, S. A., Knight, C. G., Malone, J. G., Robinson, Z., Spiers, A. J., Harris, S., Challis, G. L., Yaxley, A. M., Harris, D., Seeger, K., Murphy, L., Rutter, S., Squares, R., Quail, M. A., Saunders, E., Mavromatis, K., Brettin, T. S., Bentley, S. D., Hothersall, J., Stephens, E., Thomas, C. M., Parkhill, J., Levy, S. B., Rainey, P. B., and Thomson, N. R. (2009). Genomic and genetic analyses of diversity and plant interactions of Pseudomonas fluorescens. Genome Biol. 10, R51.
167. Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D'argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., Burns, J. L., Kaul, R., and Olson, M. V. (2006). Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. U.S.A. 103, 8487-8492.
168. Speert, D. P., Campbell, M. L., Puterman, J., Govan, J., Doherty, C., Hoiby, N., Ojeniyi, B., Lam, J. S., Ogle, J. W., Johnson, Z., Paranchych, W., Sastry, P. A., Pitt, T. L., and Lawrence, L. (1994). A multicenter comparison of methods for typing strains of Pseudomonas aeruginosa predominantly from patients with cystic fibrosis. The International Pseudomonas aeruginosa Typing Study Group. J. Infect. Dis. 169, 134-142.
169. Spencer, D. H., Kas, A., Smith, E. E., Raymond, C. K., Sims, E. H., Hastings, M., Burns, J. L., Kaul, R., and Olson, M. V. (2003). Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J. Bacteriol. 185, 1316-1325.
170. Stanislavsky, E. S., and Lam, J. S. (1997). Pseudomonas aeruginosa antigens as potential vaccines. FEMS Microbiol. Rev. 21, 243-277.
171. Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., Garber, R. L., Goltry, L., Tolentino, E., Westbrock-Wadman, S., Yuan, Y., Brody, L. L., Coulter, S. N., Folger, K. R., Kas, A., Larbig, K., Lim, R., Smith, K., Spencer, D., Wong, G. K., Wu, Z., Paulsen, I. T., Reizer, J., Saier, M. H., Hancock, R. E., Lory, S., and Olson, M. V. (2000). Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406, 959-964.
172. Takada, H., and Kotani, S. (1992). "Structure-function relationships of lipid A," in Bacterial Endotoxic Lipopolysaccharides, Vol. I, Molecular Biochemistry and Cellular Biology, eds D. C. Morrison and J. L. Ryan (Boca Raton. FL: CRC press), 107-134.
173. Temple, G. S., Ayling, P. D., and Wilkinson, S. G. (1986). Isolation and characterization of a lipopolysaccharide-specific bacteriophage of Pseudomonas aeruginosa. Microbios 45, 81-91.
174. To, T. (2006). Purification and Characterization of WapP of Pseudomonas aeruginosa, a Putative Lipopolysaccharide Kinase. M.Sc. thesis, University of Guelph, Guelph
175. Trent, M. S. (2004). Biosynthesis, transport, and modification of lipid A. Biochem. Cell Biol. 82, 71-86.
176. Walker, S. G., and Beveridge, T. J. (1988). Amikacin disrupts the cell envelope of Pseudomonas aeruginosa ATCC 9027. Can. J. Microbiol. 34, 12-18.
177. Walsh, A. G., Matewish, M. J., Burrows, L. L., Monteiro, M. A., Perry, M. B., and Lam, J. S. (2000). Lipopolysaccharide core phosphates are required for viability and intrinsic drug resistance in Pseudomonas aeruginosa. Mol. Microbiol. 35, 718-727.
178. Wang, J., Lory, S., Ramphal, R., and Jin, S. (1996). Isolation and characterization of Pseudomonas aeruginosa genes inducible by respiratory mucus derived from cystic fibrosis patients. Mol. Microbiol. 22, 1005-1012.
179. Weisner, A. M., Chart, H., Bush, A., Davies, J. C., and Pitt, T. L. (2007). Detection of antibodies to Pseudomonas aeruginosa in serum and oral fluid from patients with cystic fibrosis. J. Med. Microbiol. 56, 670-674.
180. Wenzel, C. Q., Daniels, C., Keates, R. A., Brewer, D., and Lam, J. S. (2005). Evidence that WbpD is an N-acetyltransferase belonging to the hexapeptide acyltransferase superfamily and an important protein for O-antigen biosynthesis in Pseudomonas aeruginosa PAO1. Mol. Microbiol. 57, 1288-1303.
181. Westman, E. L., Mcnally, D. J., Charchoglyan, A., Brewer, D., Field, R. A., and Lam, J. S. (2009). Characterization of WbpB, WbpE, and WbpD and reconstitution of a pathway for the biosynthesis of UDP-2,3-diacetamido-2,3-dideoxy-d-mannuronic acid in Pseudomonas aeruginosa. J. Biol. Chem. 284, 11854-11862.
182. Westman, E. L., Preston, A., Field, R. A., and Lam, J. S. (2008). Biosynthesis of a rare Di-N-Acetylated Sugar in the lipopolysaccharides of both Pseudomonas aeruginosa and Bordetella pertussis occurs via an identical scheme despite different gene clusters. J. Bacteriol. 190, 6060-6069.
183. Whiteley, M., Lee, K. M., and Greenberg, E. P. (1999). Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U.S.A. 96, 13904-13909.
184. Whitfield, C. (1995). Biosynthesis of lipopolysaccharide O antigens. Trends Microbiol. 3, 178-185.
185. Winn, A. M., and Wilkinson, S. G. (1998). The O7 antigen of Stenotrophomonas maltophilia is a linear d-rhamnan with a trisaccharide repeating unit that is also present in polymers for some Pseudomonas and Burkholderia species. FEMS Microbiol. Lett. 166, 57-61.
186. Winstanley, C., Langille, M. G., Fothergill, J. L., Kukavica-Ibrulj, I., Paradis-Bleau, C., Sanschagrin, F., Thomson, N. R., Winsor, G. L., Quail, M. A., Lennard, N., Bignell, A., Clarke, L., Seeger, K., Saunders, D., Harris, D., Parkhill, J., Hancock, R. E., Brinkman, F. S., and Levesque, R. C. (2009). Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool epidemic strain of Pseudomonas aeruginosa. Genome Res. 19, 12-23.
187. Wolfgang, M. C., Kulasekara, B. R., Liang, X., Boyd, D., Wu, K., Yang, Q., Miyada, C. G., and Lory, S. (2003). Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U.S.A. 100, 8484-8489.
188. Wyckoff, T. J., Lin, S., Cotter, R. J., Dotson, G. D., and Raetz, C. R. (1998). Hydrocarbon rulers in UDP-N-acetylglucosamine acyltransferases. J. Biol. Chem. 273, 32369-32372.
189. Yang, H., Matewish, M., Loubens, I., Storey, D. G., Lam, J. S., and Jin, S. (2000). migA, a quorum-responsive gene of Pseudomonas aeruginosa, is highly expressed in the cystic fibrosis lung environment and modifies low-molecular-mass lipopolysaccharide. Microbiology 146, 2509-2519.
190. Yokota, S., Hayashi, T., and Matsumoto, H. (1994). Identification of the lipopolysaccharide core region as the receptor site for a cytotoxin-converting phage, phi CTX, of Pseudomonas aeruginosa. J. Bacteriol. 176, 5262-5269.
191. Yokota, S., Kaya, S., Sawada, S., Kawamura, T., Araki, Y., and Ito, E. (1987). Characterization of a polysaccharide component of lipopolysaccharide from Pseudomonas aeruginosa IID 1008 (ATCC 27584) as d-rhamnan. Eur. J. Biochem. 167, 203-209.
192. Zaidi, T. S., Lyczak, J., Preston, M., and Pier, G. B. (1999). Cystic fibrosis transmembrane conductance regulator-mediated corneal epithelial cell ingestion of Pseudomonas aeruginosa is a key component in the pathogenesis of experimental murine keratitis. Infect. Immun. 67, 1481-1492.
193. Zhao, X., and Lam, J. S. (2002). WaaP of Pseudomonas aeruginosa is a novel eukaryotic type protein-tyrosine kinase as well as a sugar kinase essential for the biosynthesis of core lipopolysaccharide. J. Biol. Chem. 277, 4722-4730.
194. Zhao, X., Wenzel, C. Q., and Lam, J. S. (2002). Nonradiolabeling assay for WaaP, an essential sugar kinase involved in biosynthesis of core lipopolysaccharide of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46, 2035-2037.
195. Zuercher, A. W., Horn, M. P., Que, J. U., Ruedeberg, A., Schoeni, M. H., Schaad, U. B., Marcus, P., and Lang, A. B. (2006). Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis. FEMS Immunol. Med. Microbiol. 47, 302-308.